MedPath

The effect of chitosan spray on bleeding and wound healing following tear duct surgery.

Phase 2
Conditions
To evaluate the effect of topical chitosan spray on haemostasis and wound healing following endoscopic dacryocystorhinostomy (endoDCR) without intubation.
Eye - Diseases / disorders of the eye
Registration Number
ACTRN12609001028291
Lead Sponsor
South Australian Institute of Ophthalmology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
26
Inclusion Criteria

All patients over the age of 18 years, who are able to give written informed consent.

All patients with primary acquired nasolacrimal duct obstruction (PANLDO) as confirmed by clinical examination and radiological investigations (dacryocystography -/+ lacrimal scintigraphy).

Adequate renal function (glomerular filtration calculated by Cockcroft/Gault formula or measure urine creatinine clearance > or = to 50 mL/minute)

Exclusion Criteria

All patients with canalicular disease (obstruction/ stenosis), found either pre-operatively or at the time of surgery.

All patients with a history of previous nasolacrimal surgery (DCR).

All patients not willing to participate in the study.

Any patient with an allergy to shell/fish as this compound is a product of squid skeletons.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath